Market Turmoil: Dow Futures Dip, AI Giant Stumbles – Analyst Insightsby Terry Bingman 12.02.2024Dow Jones futures fell ahead of the consumer price index inflation report, causing market sentiment to be cautious. Investors are ...
Uber Surpasses Profit Expectations in 14th Yearby Mark Eisenberg 12.02.2024Uber reports first annual profit in 14 years, beating analyst estimates. Gross bookings and total trips taken showed significant growth. ...
Saudi Market Hits Record High: Pharma Leads, Oil Slipsby Terry Bingman 12.02.2024The Saudi Arabia stock market hits a new 52-week high as pharmaceutical and telecom stocks surge, attracting investor attention.
Seaport Global: Neutral Rating on The Trade Deskby Mark Eisenberg 12.02.2024Seaport Global initiates coverage of The Trade Desk with a Neutral rating, citing its dominant position in digital advertising and ...
Bank of America Analysts: Small-Caps the Market’s Hidden Gemby Mark Eisenberg 12.02.2024Despite the market rally, small-cap stocks have become cheaper, making them an attractive option for investors. Bank of America analysts ...
Shopify Stock Surge: Truist Sets $90 Targetby Mark Eisenberg 12.02.2024Truist Securities raises price target for Shopify shares ahead of earnings report, predicting strong growth potential. Market sentiment is positive.
Novo Nordisk’s Sales Surge: Eyeing $7B Annual Investmentby Mark Eisenberg 12.02.2024Novo Nordisk sees massive sales jump and expects further growth in 2024, driven by the demand for its diabetes and ...
Shell’s Bonny Terminal Fuels Nigeria’s Refinery Revival.by Mark Eisenberg 12.02.2024Shell Nigeria has resumed oil supply to the Port Harcourt Refinery after a five-year outage, reducing the country's dependence on ...
enCore Energy Corp.: $20M Debt Cleared for Growthby Mark Eisenberg 12.02.2024enCore Energy Corp. has eliminated its debt by converting a promissory note into common shares, becoming debt-free and positioning itself ...
Bristol Myers Bags RayzeBio in $4.1B Cancer Fight Pactby Mark Eisenberg 12.02.2024Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...